Patent classifications
A61K31/01
Pharmaceutical composition to treat health conditions associated with elevated glucose levels
A threefold decrease in α-amylase inhibition, increase in insulin secretion and glucose uptake increase by the pharmaceutical composition of several naturally occurring substances and vitamins were observed when compared to the control cells, and a c.a. 1-1.5 fold decrease when compared to the positive control. More specifically Mix A and Mix B applied together with VitaminD+K2 shows significant effect on increased insulin secretion and glucose uptake by cells.
METHOD OF IMPROVING VISUAL PROCESSING, VISUAL ACUITY, OR BOTH BY ADMINISTERING COMPOSITIONS COMPRISING RRR-ALPHA-TOCOPHEROL AND CAROTENOID TO INFANTS
Methods for improving the visual processing of a healthy infant by administering a composition comprising RRR-alpha-tocopherol and a carotenoid to the infant are disclosed. Methods for improving the visual acuity of a healthy infant by administering a composition comprising RRR-alpha-tocopherol and a carotenoid to the infant are also disclosed. Methods for improving the visual processing of a healthy infant by administering a composition comprising RRR-alpha-tocopherol to the infant are disclosed. Methods for improving the visual acuity of a healthy infant by administering a composition comprising RRR-alpha-tocopherol to the infant are also disclosed. Methods for improving the development of the visual processing, visual acuity, or both, of an infant by administering a composition comprising RRR-alpha-tocopherol to the infant are also disclosed.
METHOD OF IMPROVING VISUAL PROCESSING, VISUAL ACUITY, OR BOTH BY ADMINISTERING COMPOSITIONS COMPRISING RRR-ALPHA-TOCOPHEROL AND CAROTENOID TO INFANTS
Methods for improving the visual processing of a healthy infant by administering a composition comprising RRR-alpha-tocopherol and a carotenoid to the infant are disclosed. Methods for improving the visual acuity of a healthy infant by administering a composition comprising RRR-alpha-tocopherol and a carotenoid to the infant are also disclosed. Methods for improving the visual processing of a healthy infant by administering a composition comprising RRR-alpha-tocopherol to the infant are disclosed. Methods for improving the visual acuity of a healthy infant by administering a composition comprising RRR-alpha-tocopherol to the infant are also disclosed. Methods for improving the development of the visual processing, visual acuity, or both, of an infant by administering a composition comprising RRR-alpha-tocopherol to the infant are also disclosed.
Method and composition for ameliorating drug seeking behavior
A composition and method for ameliorating drug-seeking behavior in drug addicts who have stopped using the addicted-to drug and who have reestablished non-addict physiological chemical balance.
Method and composition for ameliorating drug seeking behavior
A composition and method for ameliorating drug-seeking behavior in drug addicts who have stopped using the addicted-to drug and who have reestablished non-addict physiological chemical balance.
COMPOSITION FOR ALLERGY PREVENTION, ATOPIC DERMATITIS ALLEVIATION OR SKIN REGENERATION, CONTAINING, AS ACTIVE INGREDIENT, UNDECANE OR UNDECANAL
The present invention relates to a composition for allergy prevention, atopic dermatitis alleviation or skin regeneration, containing, as an active ingredient, undecane or undecanal and, more specifically, to a composition for preventing or treating allergic disease or atopic dermatitis and a composition for healing skin wound or promoting skin regeneration, both of which contain, as an active ingredient, at least one selected from a group consisting of undecane, undecanal or pharmaceutically acceptable salts thereof.
COMPOSITION FOR ALLERGY PREVENTION, ATOPIC DERMATITIS ALLEVIATION OR SKIN REGENERATION, CONTAINING, AS ACTIVE INGREDIENT, UNDECANE OR UNDECANAL
The present invention relates to a composition for allergy prevention, atopic dermatitis alleviation or skin regeneration, containing, as an active ingredient, undecane or undecanal and, more specifically, to a composition for preventing or treating allergic disease or atopic dermatitis and a composition for healing skin wound or promoting skin regeneration, both of which contain, as an active ingredient, at least one selected from a group consisting of undecane, undecanal or pharmaceutically acceptable salts thereof.
Hydrolyzed Pea Protein-Based Nutrient Composition
The present invention discloses a nutritional composition and method of using and making the nutritional composition. The nutritional composition is a hydrolyzed pea protein based nutrient composition for use in both enteral and oral feeding, and provides a non-allergenic diet for providing optimal nutrition to users. The nutritional composition is made from organic and plant-based ingredients. The nutritional composition has pea protein hydrolysates, phytochemical extracts, fatty acids, organic ingredients free of the top eight allergens and corn, and prebiotic fiber. The nutritional composition is provided in liquid form for enteral and/or oral feeding.
Hydrolyzed Pea Protein-Based Nutrient Composition
The present invention discloses a nutritional composition and method of using and making the nutritional composition. The nutritional composition is a hydrolyzed pea protein based nutrient composition for use in both enteral and oral feeding, and provides a non-allergenic diet for providing optimal nutrition to users. The nutritional composition is made from organic and plant-based ingredients. The nutritional composition has pea protein hydrolysates, phytochemical extracts, fatty acids, organic ingredients free of the top eight allergens and corn, and prebiotic fiber. The nutritional composition is provided in liquid form for enteral and/or oral feeding.
FORMULATIONS FOR TREATING CLUSTER SYMPTOMS ASSOCIATED WITH AUTISM SPECTRUM DISORDER
The present disclosure provides for pharmaceutical compositions useful for treating autism spectrum disorder. The pharmaceutical compositions comprise particular THC:CBD ratios and terpene profiles, which have been demonstrated effective at treating cluster symptoms associated with autism spectrum disorder.